Screening for Epidermal Growth Factor Receptor Mutations in Lung CancerRafael Rosell, Miquel Tarón, Teresa Morán et al.|New England Journal of Medicine|2009Cited by 2.4k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung CancerYi‐Long Wu, Roy S. Herbst, Charuwan Akewanlop et al.|New England Journal of Medicine|2020Cited by 1.7k
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung CancerHeather A. Wakelee, Jonathan Spicer, Moïshe Liberman et al.|New England Journal of Medicine|2023Cited by 1k
Overall Survival with Osimertinib in Resected <i>EGFR</i> -Mutated NSCLCMasahiro Tsuboi, Yi‐Long Wu, Roy S. Herbst et al.|New England Journal of Medicine|2023Cited by 605
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA TrialRoy S. Herbst, Masahiro Tsuboi, Yi‐Long Wu et al.|Journal of Clinical Oncology|2023Cited by 386